BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 22421165)

  • 21. Dopamine D3 receptor is decreased and D2 receptor is elevated in the striatum of Parkinson's disease.
    Ryoo HL; Pierrotti D; Joyce JN
    Mov Disord; 1998 Sep; 13(5):788-97. PubMed ID: 9756147
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Self-rated intensity of habitual physical activities is positively associated with dopamine D
    Köhncke Y; Papenberg G; Jonasson L; Karalija N; Wåhlin A; Salami A; Andersson M; Axelsson JE; Nyberg L; Riklund K; Bäckman L; Lindenberger U; Lövdén M
    Neuroimage; 2018 Nov; 181():605-616. PubMed ID: 30041059
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Decreased binding of the D3 dopamine receptor-preferring ligand [11C]-(+)-PHNO in drug-naive Parkinson's disease.
    Boileau I; Guttman M; Rusjan P; Adams JR; Houle S; Tong J; Hornykiewicz O; Furukawa Y; Wilson AA; Kapur S; Kish SJ
    Brain; 2009 May; 132(Pt 5):1366-75. PubMed ID: 19153147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Attenuation of fluctuating striatal synaptic dopamine levels in patients with Parkinson disease in response to subthalamic nucleus stimulation: a positron emission tomography study.
    Nimura T; Yamaguchi K; Ando T; Shibuya S; Oikawa T; Nakagawa A; Shirane R; Itoh M; Tominaga T
    J Neurosurg; 2005 Dec; 103(6):968-73. PubMed ID: 16381182
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effects of dopamine D2 receptor partial agonist antipsychotic aripiprazole on dopamine synthesis in human brain measured by PET with L-[β-11C]DOPA.
    Ito H; Takano H; Arakawa R; Takahashi H; Kodaka F; Takahata K; Nogami T; Suzuki M; Suhara T
    PLoS One; 2012; 7(9):e46488. PubMed ID: 23029533
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Upregulation of putaminal dopamine D2 receptors in early Parkinson's disease: a comparative PET study with [11C] raclopride and [11C]N-methylspiperone.
    Kaasinen V; Ruottinen HM; Någren K; Lehikoinen P; Oikonen V; Rinne JO
    J Nucl Med; 2000 Jan; 41(1):65-70. PubMed ID: 10647606
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of (S)-ketamine on striatal dopamine: a [11C]raclopride PET study of a model psychosis in humans.
    Vollenweider FX; Vontobel P; Oye I; Hell D; Leenders KL
    J Psychiatr Res; 2000; 34(1):35-43. PubMed ID: 10696831
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relation of putamen and caudate nucleus 18F-Dopa uptake to motor and cognitive performances in Parkinson's disease.
    Broussolle E; Dentresangle C; Landais P; Garcia-Larrea L; Pollak P; Croisile B; Hibert O; Bonnefoi F; Galy G; Froment JC; Comar D
    J Neurol Sci; 1999 Jul; 166(2):141-51. PubMed ID: 10475108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Dopaminergic activities in the human striatum: rostrocaudal gradients of uptake sites and of D1 and D2 but not of D3 receptor binding or dopamine.
    Piggott MA; Marshall EF; Thomas N; Lloyd S; Court JA; Jaros E; Costa D; Perry RH; Perry EK
    Neuroscience; 1999 May; 90(2):433-45. PubMed ID: 10215149
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Regulation of dopamine D₃ receptor in the striatal regions and substantia nigra in diffuse Lewy body disease.
    Sun J; Cairns NJ; Perlmutter JS; Mach RH; Xu J
    Neuroscience; 2013 Sep; 248():112-26. PubMed ID: 23732230
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Brain region binding of the D2/3 agonist [11C]-(+)-PHNO and the D2/3 antagonist [11C]raclopride in healthy humans.
    Graff-Guerrero A; Willeit M; Ginovart N; Mamo D; Mizrahi R; Rusjan P; Vitcu I; Seeman P; Wilson AA; Kapur S
    Hum Brain Mapp; 2008 Apr; 29(4):400-10. PubMed ID: 17497628
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Quinpirole elicits differential in vivo changes in the pre- and postsynaptic distributions of dopamine D₂ receptors in mouse striatum: relation to cannabinoid-1 (CB₁) receptor targeting.
    Lane DA; Chan J; Fitzgerald ML; Kearn CS; Mackie K; Pickel VM
    Psychopharmacology (Berl); 2012 May; 221(1):101-13. PubMed ID: 22160162
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A PET study with [11-C]raclopride in Parkinson's disease: preliminary results on the effect of amantadine on the dopaminergic system.
    Volonté MA; Moresco RM; Gobbo C; Messa C; Carpinelli A; Rizzo G; Comi G; Fazio F
    Neurol Sci; 2001 Feb; 22(1):107-8. PubMed ID: 11487182
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Autoradiographic mapping of dopamine-D2/D3 receptor stimulated [35S]GTPgammaS binding in the human brain.
    Sóvágó J; Makkai B; Gulyás B; Hall H
    Eur J Neurosci; 2005 Jul; 22(1):65-71. PubMed ID: 16029196
    [TBL] [Abstract][Full Text] [Related]  

  • 35. In vitro and in vivo comparison of [³H](+)-PHNO and [³H]raclopride binding to rat striatum and lobes 9 and 10 of the cerebellum: a method to distinguish dopamine D₃ from D₂ receptor sites.
    Kiss B; Horti F; Bobok A
    Synapse; 2011 Jun; 65(6):467-78. PubMed ID: 20936685
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Recovery of dopamine transporters with methamphetamine detoxification is not linked to changes in dopamine release.
    Volkow ND; Wang GJ; Smith L; Fowler JS; Telang F; Logan J; Tomasi D
    Neuroimage; 2015 Nov; 121():20-8. PubMed ID: 26208874
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Autoradiographic visualization of dopamine D-2 receptors in the monkey brain using the selective benzamide drug [3H]raclopride.
    Köhler C; Radesäter AC
    Neurosci Lett; 1986 May; 66(1):85-90. PubMed ID: 2940480
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effects of acute nicotine on hemodynamics and binding of [11C]raclopride to dopamine D2,3 receptors in pig brain.
    Cumming P; Rosa-Neto P; Watanabe H; Smith D; Bender D; Clarke PB; Gjedde A
    Neuroimage; 2003 Jul; 19(3):1127-36. PubMed ID: 12880838
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Dopamine D2 and D3 receptors in human putamen, caudate nucleus, and globus pallidus.
    Seeman P; Wilson A; Gmeiner P; Kapur S
    Synapse; 2006 Sep; 60(3):205-11. PubMed ID: 16739118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Oral methylphenidate fails to elicit significant changes in extracellular putaminal dopamine levels in Parkinson's disease patients: positron emission tomographic studies.
    Koochesfahani KM; de la Fuente-Fernández R; Sossi V; Schulzer M; Yatham LN; Ruth TJ; Blinder S; Stoessl AJ
    Mov Disord; 2006 Jul; 21(7):970-5. PubMed ID: 16570297
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.